Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquired_by |
gptkb:Johnson_&_Johnson
|
| gptkbp:acquisition_year |
gptkb:1999
|
| gptkbp:awards |
Best Places to Work
Various industry awards Innovation awards Research excellence awards Corporate social responsibility awards |
| gptkbp:clinical_trial |
Post-marketing studies
Phase III trials Phase I trials Phase II trials Long-term safety studies Various therapeutic areas |
| gptkbp:employees |
Approximately 1,000
|
| gptkbp:focus_area |
gptkb:Cardiovascular_diseases
gptkb:Oncology Autoimmune diseases Infectious diseases Inflammatory diseases |
| gptkbp:founded |
gptkb:1979
|
| gptkbp:founder |
Dr. Paul J. Mc Gowan
|
| gptkbp:global_presence |
gptkb:Europe
gptkb:Middle_East gptkb:Asia gptkb:Latin_America gptkb:North_America |
| gptkbp:headquarters |
gptkb:Malvern,_Pennsylvania
|
| https://www.w3.org/2000/01/rdf-schema#label |
Centocor
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:key_people |
gptkb:Dr._John_A._Mc_Gowan
Dr. Paul J. Mc Gowan Dr. William H. Hsu |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:notable_products |
gptkb:Stelara
gptkb:Remicade Simponi |
| gptkbp:parent_company |
gptkb:Johnson_&_Johnson
|
| gptkbp:part_of |
Johnson & Johnson Pharmaceutical Research & Development
|
| gptkbp:partnerships |
Various academic institutions
Various healthcare organizations Various biotechnology companies |
| gptkbp:philanthropy |
Research funding
Patient support programs Community health programs Various health initiatives Disease awareness campaigns |
| gptkbp:research_and_development |
Biologics
Monoclonal antibodies Therapeutic proteins |
| gptkbp:revenue |
$1.5 billion (2010)
|
| gptkbp:specializes_in |
biopharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Johnson_&_Johnson
|
| gptkbp:website |
www.centocor.com
|
| gptkbp:bfsParent |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:bfsLayer |
5
|